MUI, Medizinischen Universität Innsbruck (Division of Physiology, DP)

MUI is a young research centre, founded in 2004, with 3 000 students. It is the most important medical research and training facility in western Austria. It has 10 administrative divisions, 9 preclinical departments with 22 divisions and 21 clinical units. DP is part of the Dept. Physiology & Medical Physics and has six working groups whose major research focus are nociception, calcium signalling, cell membranes and renal and alveolar epithelial physiology.

UKW, Universitätsklinikum Würzburg (Dept. of Neurology, DN)

UKW is an independent public higher education University Hospital with 19 Departments including ambulatory centres as well as four scientific institutes. The UKW is academically part of the University of Würzburg, a public institution, and belongs to the Medical Faculty. Per year > 55 000 patients are treated at UKW and > 200 000 are treated as outpatients. DN has particular and long-standing clinical and research expertise in the field of peripheral neuropathies and neuropathic pain. In the last decade, several human and animal research studies on the pathophysiology of neuropathic pain have been performed at DN.

Bionorica research GmbH

Bionorica research GmbH is a subsidiary of Bionorica SE, a leading German manufacturer of herbal medicines worldwide, in Innsbruck, Austria. The business is committed to discovering and utilizing active plant ingredients for the development of rational phytopharmaceuticals. His research is focused on analytical investigation of natural products and complex herbal mixtures. For this purpose a new laboratory was established in 2008. With this lab, Bionorica research has a wide range of high-end analytical instruments available for analytical investigation of complex samples like biological fluids or herbal material. Furthermore, Bionorica research has a strong expertise for preparative purification of plant constituents as well as for the separation of complex mixtures. In 2010 and 2014 the laboratories and the equipment were expanded.

Friedrich-Schiller University Jena (FSU), Universitätsklinikum Jena (UKJ) – Jena University Hospital, Institute of Physiology I (Neurophysiology), UP1

FSU was established in 1558 and is counted among the 20 oldest universities in Germany. It is affiliated with 6 Nobel Prize winners. The Medical Faculty of the FSU (UKJ) with its 25 clinical centers and 27 institutes provides care for 250 000 in- and outpatients per year and teaching for 2 200 students of medicine and dentistry. UP1 is one of the largest centers of preclinical pain research in Germany with a main focus on musculoskeletal pain.

Kancera AB

Kancera AB is a preclinical stage biotech company developing small molecule drugs against cancer and cancer-associated pain. The company is since 2011 listed on Nasdaq First North in Stockholm. The company is currently developing drugs for the treatment of leukemia and solid tumors, based partly on blocking survival signals in the cancer cell and partly on metabolic strangulation.

Eli Lilly and Company Ltd (Erl Wood Neuroscience Research Centre)

Eli Lilly was founded in 1876, with headquarters located in Indianapolis, US, and with operations based in the US and EU. Eli Lilly is now the tenth largest pharmaceutical company in the world with circa 39 000 employees, of which 8 000 are working in R&D. Eli Lilly has a broad interest in developing new therapies in the areas of neurodegenerative diseases and pain. Eli Lilly has been operating in the UK since 1934 and has four sites: UK Headquarters in Basingstoke, Erl Wood Research Centre in Windlesham, Speke Manufacturing Operations in Liverpool, and Bio-Tech Manufacturing in Dundee. Today, over 600 people, representing 45 different nationalities and 30 different functional disciplines, work at Erl Wood on both discovery and development of the new potential medicines in the pipeline.